PAVIAgroup photoPAVIAgroup photo

PAVIA ANNUAL MEETING 2018, TANZANIA

PAVIA BLENDED TRAINING IN COORDINATION WITH VERONA TEAM

PAVIA ANNUAL CONSORTIUM MEETING 2019, ETHIOPIA

3rd PAVIA training

About Us & What We Do

The PAVIA project aims to strengthen pharmacovigilance (PV) in four African countries: Ethiopia, Eswatini, Nigeria, and Tanzania. To achieve this aim, collaborative support will be harnessed across several institutions in Europe and Africa.

Workpackage

WP 1 deals with Coordination and Management. In this WP implementation of the collaboration…  more

WP2 is on Policy, Laws, and Regulations. In this WP, we will support the target countries to address the relevant policies…  more

WP3 is about Data collection and Signal Detection, including Data Management Measures. In this WP, we work… more

WP4 deals with Monitoring and Evaluation. The objective of this WP is to measure the impact of our PV activities in a…  more

WP5 entails System, Structure, and Stakeholder Measures. This WP aims to strengthen organizational structures…  more

Our Achievements

What does the PAVIA team say

The  Following People are Part of PAVIA

 

Our Team

Our  Participants in PAVIA Project

Following are participants involved in PAVIA Project

News and Events

 

Tanzania Achievements

TANZANIA Training Staff from The Tanzania Medicines and Medical Devices Authority (TMDA) attended the third (3rd) PAVIA training which was conducted from 14-18 June, 2021. The training was facilitated by the Lareb, the European Medicine Agency (EMA) and FDA Ghana. The training aimed at building... ...

Ethiopia Achievements

Supportive Supervision was conducted on general pharmacovigilance and Active TB-Drugs Safety Monitoring and Management (aDSM) Ethiopia has implemented different regimens for treatment of Multi Drug Resistant Tuberculosis (MDR-TB) and introduced new anti TB drugs (bedaquiline (Bdq) and delamanid (Dlm) and repurposed drugs (clofazimine and linezolid)... ...

1ST MEETING OF aDSM CAUSALITY ASSESSMENT COMMITTEE AT KNCV CONFERENCE HALL 24TH – 25TH JUNE 2021

1ST MEETING OF aDSM CAUSALITY ASSESSMENT COMMITTEE AT KNCV CONFERENCE HALL 24TH – 25TH JUNE 2021 Background Active Drug Safety Monitoring (aDSM) is an active form of pharmacovigilance recommended by the WHO for active and systematic clinical and laboratory assessment of patients on treatment with... ...

PAVIA at 50th Union Conference

Symposium session proposal: Sustainable models for strengthening pharmacovigilance of TB medicines and diagnostics: global and regional perspectives and country examples.  .  . ...